The drugmaker plans to launch Semaglutide in 87 countries next year, including those where patents are expiring and emerging ...

Stocks including Infosys, RIL, Dr Reddy's Labs, Tata Consumer Products, IndusInd Bank, BEML, Bajaj Housing, Tilaknagar Industries and more will be in the spotlight on Thursday, July 24.

India's stock benchmarks will likely open marginally higher on Thursday, lifted by robust earnings from Infosys and optimism ...

MDC rejects Dr Reddy's application to fix separate price for Omaze ODT: Our Bureau, New Delhi Thursday, July 24, 2025, 08:00 Hrs [IST] The Multidisciplinary Committee (MDC) of Exp ...

Global markets staged a strong trajectory as well, with the S&P 500 rising by 49 points or 0.78 per cent, concluding the ...

June earnings season gains pace, several major companies, including Infosys, IndusInd Bank, Dr. Reddy’s, and Tilaknagar Industries, have announced key financial updates, acquisitions, and fundraising ...

Initially, Dr Reddy's will focus on launching the generic semaglutide in Canada, India, Brazil, Turkey, and other emerging ...

The NSE Nifty 50 may start Thursday's session on a tepid note. The index will likely get support at 25,100 and face resistance at 25,320 level. Asia-pacific share indices were trading high on optimism ...

NDTV Profit tracked analysts' views on various stocks and sectors. Here are the analyst calls to keep an eye out for today.

Are you one of those stressing over your smartwatch readings, wondering whether you have made 10,000 steps by the end of day? Now a new study in ‘The Lancet Public Health’ says that 7,000 steps per ...

Apollo Hospitals and Siemens Healthineers launch a groundbreaking collaboration to enhance liver disease management through AI and imaging technologies, focusing on early detection, precise monitoring ...

Q1 may have held steady, but the second half of FY26 will test Dr Reddy’s transition strategy. Without Revlimid, and with US pressure persisting, the Street will now watch execution timelines — not ...